nodes	percent_of_prediction	percent_of_DWPC	metapath
Oxcarbazepine—CYP3A5—Ifosfamide—testicular cancer	0.156	0.279	CbGbCtD
Oxcarbazepine—CYP2C19—Ifosfamide—testicular cancer	0.125	0.225	CbGbCtD
Oxcarbazepine—CYP3A5—Etoposide—testicular cancer	0.0743	0.133	CbGbCtD
Oxcarbazepine—ALB—Methotrexate—testicular cancer	0.0611	0.11	CbGbCtD
Oxcarbazepine—CYP3A4—Ifosfamide—testicular cancer	0.0607	0.109	CbGbCtD
Oxcarbazepine—CYP3A4—Vinblastine—testicular cancer	0.0322	0.0577	CbGbCtD
Oxcarbazepine—CYP3A4—Etoposide—testicular cancer	0.029	0.0519	CbGbCtD
Oxcarbazepine—CYP3A4—Doxorubicin—testicular cancer	0.0198	0.0354	CbGbCtD
Oxcarbazepine—Infestation—Doxorubicin—testicular cancer	0.000283	0.00064	CcSEcCtD
Oxcarbazepine—Visual impairment—Methotrexate—testicular cancer	0.000282	0.000639	CcSEcCtD
Oxcarbazepine—Stevens-Johnson syndrome—Doxorubicin—testicular cancer	0.00028	0.000634	CcSEcCtD
Oxcarbazepine—Vomiting—Ifosfamide—testicular cancer	0.00028	0.000633	CcSEcCtD
Oxcarbazepine—Hypersensitivity—Cisplatin—testicular cancer	0.00028	0.000633	CcSEcCtD
Oxcarbazepine—Bradycardia—Epirubicin—testicular cancer	0.000279	0.000632	CcSEcCtD
Oxcarbazepine—Renal failure—Doxorubicin—testicular cancer	0.000278	0.000629	CcSEcCtD
Oxcarbazepine—Rash—Ifosfamide—testicular cancer	0.000278	0.000628	CcSEcCtD
Oxcarbazepine—Dermatitis—Ifosfamide—testicular cancer	0.000277	0.000627	CcSEcCtD
Oxcarbazepine—Erythema multiforme—Methotrexate—testicular cancer	0.000277	0.000627	CcSEcCtD
Oxcarbazepine—Urticaria—Etoposide—testicular cancer	0.000276	0.000625	CcSEcCtD
Oxcarbazepine—Stomatitis—Doxorubicin—testicular cancer	0.000276	0.000624	CcSEcCtD
Oxcarbazepine—Rhinitis—Epirubicin—testicular cancer	0.000275	0.000622	CcSEcCtD
Oxcarbazepine—Body temperature increased—Etoposide—testicular cancer	0.000275	0.000622	CcSEcCtD
Oxcarbazepine—Abdominal pain—Etoposide—testicular cancer	0.000275	0.000622	CcSEcCtD
Oxcarbazepine—Urinary tract infection—Doxorubicin—testicular cancer	0.000275	0.000622	CcSEcCtD
Oxcarbazepine—Hepatitis—Epirubicin—testicular cancer	0.000274	0.000621	CcSEcCtD
Oxcarbazepine—Eye disorder—Methotrexate—testicular cancer	0.000274	0.00062	CcSEcCtD
Oxcarbazepine—Tinnitus—Methotrexate—testicular cancer	0.000273	0.000618	CcSEcCtD
Oxcarbazepine—Hypoaesthesia—Epirubicin—testicular cancer	0.000273	0.000618	CcSEcCtD
Oxcarbazepine—Asthenia—Cisplatin—testicular cancer	0.000272	0.000616	CcSEcCtD
Oxcarbazepine—Pharyngitis—Epirubicin—testicular cancer	0.000272	0.000616	CcSEcCtD
Oxcarbazepine—Cardiac disorder—Methotrexate—testicular cancer	0.000272	0.000615	CcSEcCtD
Oxcarbazepine—Oedema peripheral—Epirubicin—testicular cancer	0.00027	0.000611	CcSEcCtD
Oxcarbazepine—Haematuria—Doxorubicin—testicular cancer	0.00027	0.00061	CcSEcCtD
Oxcarbazepine—Hepatobiliary disease—Doxorubicin—testicular cancer	0.000267	0.000605	CcSEcCtD
Oxcarbazepine—Epistaxis—Doxorubicin—testicular cancer	0.000267	0.000603	CcSEcCtD
Oxcarbazepine—Angiopathy—Methotrexate—testicular cancer	0.000266	0.000602	CcSEcCtD
Oxcarbazepine—Sinusitis—Doxorubicin—testicular cancer	0.000265	0.0006	CcSEcCtD
Oxcarbazepine—Immune system disorder—Methotrexate—testicular cancer	0.000265	0.000599	CcSEcCtD
Oxcarbazepine—Visual impairment—Epirubicin—testicular cancer	0.000264	0.000598	CcSEcCtD
Oxcarbazepine—Agranulocytosis—Doxorubicin—testicular cancer	0.000264	0.000597	CcSEcCtD
Oxcarbazepine—Chills—Methotrexate—testicular cancer	0.000263	0.000595	CcSEcCtD
Oxcarbazepine—Nausea—Ifosfamide—testicular cancer	0.000261	0.000592	CcSEcCtD
Oxcarbazepine—Diarrhoea—Cisplatin—testicular cancer	0.00026	0.000587	CcSEcCtD
Oxcarbazepine—Erythema multiforme—Epirubicin—testicular cancer	0.000259	0.000587	CcSEcCtD
Oxcarbazepine—Alopecia—Methotrexate—testicular cancer	0.000259	0.000586	CcSEcCtD
Oxcarbazepine—Bradycardia—Doxorubicin—testicular cancer	0.000258	0.000585	CcSEcCtD
Oxcarbazepine—Mental disorder—Methotrexate—testicular cancer	0.000257	0.000581	CcSEcCtD
Oxcarbazepine—Eye disorder—Epirubicin—testicular cancer	0.000256	0.00058	CcSEcCtD
Oxcarbazepine—Hypersensitivity—Etoposide—testicular cancer	0.000256	0.00058	CcSEcCtD
Oxcarbazepine—Tinnitus—Epirubicin—testicular cancer	0.000256	0.000579	CcSEcCtD
Oxcarbazepine—Malnutrition—Methotrexate—testicular cancer	0.000255	0.000577	CcSEcCtD
Oxcarbazepine—Flushing—Epirubicin—testicular cancer	0.000255	0.000576	CcSEcCtD
Oxcarbazepine—Cardiac disorder—Epirubicin—testicular cancer	0.000255	0.000576	CcSEcCtD
Oxcarbazepine—Rhinitis—Doxorubicin—testicular cancer	0.000254	0.000576	CcSEcCtD
Oxcarbazepine—Hepatitis—Doxorubicin—testicular cancer	0.000254	0.000574	CcSEcCtD
Oxcarbazepine—Hypoaesthesia—Doxorubicin—testicular cancer	0.000253	0.000571	CcSEcCtD
Oxcarbazepine—Pharyngitis—Doxorubicin—testicular cancer	0.000252	0.00057	CcSEcCtD
Oxcarbazepine—Oedema peripheral—Doxorubicin—testicular cancer	0.00025	0.000566	CcSEcCtD
Oxcarbazepine—Dysgeusia—Methotrexate—testicular cancer	0.00025	0.000565	CcSEcCtD
Oxcarbazepine—Asthenia—Etoposide—testicular cancer	0.000249	0.000564	CcSEcCtD
Oxcarbazepine—Angiopathy—Epirubicin—testicular cancer	0.000249	0.000563	CcSEcCtD
Oxcarbazepine—Immune system disorder—Epirubicin—testicular cancer	0.000248	0.000561	CcSEcCtD
Oxcarbazepine—Back pain—Methotrexate—testicular cancer	0.000247	0.000558	CcSEcCtD
Oxcarbazepine—Chills—Epirubicin—testicular cancer	0.000246	0.000557	CcSEcCtD
Oxcarbazepine—Pruritus—Etoposide—testicular cancer	0.000246	0.000557	CcSEcCtD
Oxcarbazepine—Arrhythmia—Epirubicin—testicular cancer	0.000245	0.000554	CcSEcCtD
Oxcarbazepine—Visual impairment—Doxorubicin—testicular cancer	0.000245	0.000553	CcSEcCtD
Oxcarbazepine—Alopecia—Epirubicin—testicular cancer	0.000242	0.000548	CcSEcCtD
Oxcarbazepine—Vomiting—Cisplatin—testicular cancer	0.000241	0.000546	CcSEcCtD
Oxcarbazepine—Vision blurred—Methotrexate—testicular cancer	0.00024	0.000544	CcSEcCtD
Oxcarbazepine—Mental disorder—Epirubicin—testicular cancer	0.00024	0.000544	CcSEcCtD
Oxcarbazepine—Erythema multiforme—Doxorubicin—testicular cancer	0.00024	0.000543	CcSEcCtD
Oxcarbazepine—Rash—Cisplatin—testicular cancer	0.000239	0.000541	CcSEcCtD
Oxcarbazepine—Dermatitis—Cisplatin—testicular cancer	0.000239	0.000541	CcSEcCtD
Oxcarbazepine—Malnutrition—Epirubicin—testicular cancer	0.000239	0.00054	CcSEcCtD
Oxcarbazepine—Diarrhoea—Etoposide—testicular cancer	0.000238	0.000538	CcSEcCtD
Oxcarbazepine—Eye disorder—Doxorubicin—testicular cancer	0.000237	0.000537	CcSEcCtD
Oxcarbazepine—Ill-defined disorder—Methotrexate—testicular cancer	0.000237	0.000536	CcSEcCtD
Oxcarbazepine—Tinnitus—Doxorubicin—testicular cancer	0.000237	0.000535	CcSEcCtD
Oxcarbazepine—Flushing—Doxorubicin—testicular cancer	0.000236	0.000533	CcSEcCtD
Oxcarbazepine—Cardiac disorder—Doxorubicin—testicular cancer	0.000236	0.000533	CcSEcCtD
Oxcarbazepine—Flatulence—Epirubicin—testicular cancer	0.000235	0.000532	CcSEcCtD
Oxcarbazepine—Tension—Epirubicin—testicular cancer	0.000234	0.00053	CcSEcCtD
Oxcarbazepine—Dysgeusia—Epirubicin—testicular cancer	0.000234	0.000529	CcSEcCtD
Oxcarbazepine—Nervousness—Epirubicin—testicular cancer	0.000232	0.000525	CcSEcCtD
Oxcarbazepine—Back pain—Epirubicin—testicular cancer	0.000231	0.000523	CcSEcCtD
Oxcarbazepine—Angiopathy—Doxorubicin—testicular cancer	0.00023	0.000521	CcSEcCtD
Oxcarbazepine—Malaise—Methotrexate—testicular cancer	0.00023	0.000521	CcSEcCtD
Oxcarbazepine—Dizziness—Etoposide—testicular cancer	0.00023	0.00052	CcSEcCtD
Oxcarbazepine—Immune system disorder—Doxorubicin—testicular cancer	0.000229	0.000519	CcSEcCtD
Oxcarbazepine—Vertigo—Methotrexate—testicular cancer	0.000229	0.000519	CcSEcCtD
Oxcarbazepine—Leukopenia—Methotrexate—testicular cancer	0.000228	0.000517	CcSEcCtD
Oxcarbazepine—Chills—Doxorubicin—testicular cancer	0.000228	0.000515	CcSEcCtD
Oxcarbazepine—Arrhythmia—Doxorubicin—testicular cancer	0.000227	0.000513	CcSEcCtD
Oxcarbazepine—Nausea—Cisplatin—testicular cancer	0.000225	0.00051	CcSEcCtD
Oxcarbazepine—Vision blurred—Epirubicin—testicular cancer	0.000225	0.000509	CcSEcCtD
Oxcarbazepine—Alopecia—Doxorubicin—testicular cancer	0.000224	0.000507	CcSEcCtD
Oxcarbazepine—Cough—Methotrexate—testicular cancer	0.000223	0.000504	CcSEcCtD
Oxcarbazepine—Mental disorder—Doxorubicin—testicular cancer	0.000222	0.000503	CcSEcCtD
Oxcarbazepine—Ill-defined disorder—Epirubicin—testicular cancer	0.000222	0.000501	CcSEcCtD
Oxcarbazepine—Convulsion—Methotrexate—testicular cancer	0.000221	0.0005	CcSEcCtD
Oxcarbazepine—Vomiting—Etoposide—testicular cancer	0.000221	0.0005	CcSEcCtD
Oxcarbazepine—Malnutrition—Doxorubicin—testicular cancer	0.000221	0.0005	CcSEcCtD
Oxcarbazepine—Agitation—Epirubicin—testicular cancer	0.000219	0.000496	CcSEcCtD
Oxcarbazepine—Rash—Etoposide—testicular cancer	0.000219	0.000496	CcSEcCtD
Oxcarbazepine—Dermatitis—Etoposide—testicular cancer	0.000219	0.000496	CcSEcCtD
Oxcarbazepine—Headache—Etoposide—testicular cancer	0.000218	0.000493	CcSEcCtD
Oxcarbazepine—Flatulence—Doxorubicin—testicular cancer	0.000218	0.000493	CcSEcCtD
Oxcarbazepine—Myalgia—Methotrexate—testicular cancer	0.000217	0.000492	CcSEcCtD
Oxcarbazepine—Arthralgia—Methotrexate—testicular cancer	0.000217	0.000492	CcSEcCtD
Oxcarbazepine—Chest pain—Methotrexate—testicular cancer	0.000217	0.000492	CcSEcCtD
Oxcarbazepine—Tension—Doxorubicin—testicular cancer	0.000217	0.000491	CcSEcCtD
Oxcarbazepine—Dysgeusia—Doxorubicin—testicular cancer	0.000216	0.00049	CcSEcCtD
Oxcarbazepine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—testicular cancer	0.000216	0.000488	CcSEcCtD
Oxcarbazepine—Malaise—Epirubicin—testicular cancer	0.000215	0.000487	CcSEcCtD
Oxcarbazepine—Discomfort—Methotrexate—testicular cancer	0.000215	0.000486	CcSEcCtD
Oxcarbazepine—Nervousness—Doxorubicin—testicular cancer	0.000215	0.000486	CcSEcCtD
Oxcarbazepine—Vertigo—Epirubicin—testicular cancer	0.000215	0.000485	CcSEcCtD
Oxcarbazepine—Syncope—Epirubicin—testicular cancer	0.000214	0.000485	CcSEcCtD
Oxcarbazepine—Leukopenia—Epirubicin—testicular cancer	0.000214	0.000484	CcSEcCtD
Oxcarbazepine—Back pain—Doxorubicin—testicular cancer	0.000214	0.000484	CcSEcCtD
Oxcarbazepine—Palpitations—Epirubicin—testicular cancer	0.000211	0.000477	CcSEcCtD
Oxcarbazepine—Confusional state—Methotrexate—testicular cancer	0.00021	0.000475	CcSEcCtD
Oxcarbazepine—Loss of consciousness—Epirubicin—testicular cancer	0.00021	0.000475	CcSEcCtD
Oxcarbazepine—Cough—Epirubicin—testicular cancer	0.000208	0.000471	CcSEcCtD
Oxcarbazepine—Anaphylactic shock—Methotrexate—testicular cancer	0.000208	0.000471	CcSEcCtD
Oxcarbazepine—Vision blurred—Doxorubicin—testicular cancer	0.000208	0.000471	CcSEcCtD
Oxcarbazepine—Convulsion—Epirubicin—testicular cancer	0.000207	0.000468	CcSEcCtD
Oxcarbazepine—Infection—Methotrexate—testicular cancer	0.000207	0.000468	CcSEcCtD
Oxcarbazepine—Nausea—Etoposide—testicular cancer	0.000206	0.000467	CcSEcCtD
Oxcarbazepine—Hypertension—Epirubicin—testicular cancer	0.000206	0.000466	CcSEcCtD
Oxcarbazepine—Ill-defined disorder—Doxorubicin—testicular cancer	0.000205	0.000464	CcSEcCtD
Oxcarbazepine—Nervous system disorder—Methotrexate—testicular cancer	0.000204	0.000462	CcSEcCtD
Oxcarbazepine—Thrombocytopenia—Methotrexate—testicular cancer	0.000204	0.000461	CcSEcCtD
Oxcarbazepine—Myalgia—Epirubicin—testicular cancer	0.000203	0.00046	CcSEcCtD
Oxcarbazepine—Arthralgia—Epirubicin—testicular cancer	0.000203	0.00046	CcSEcCtD
Oxcarbazepine—Chest pain—Epirubicin—testicular cancer	0.000203	0.00046	CcSEcCtD
Oxcarbazepine—Agitation—Doxorubicin—testicular cancer	0.000203	0.000459	CcSEcCtD
Oxcarbazepine—Anxiety—Epirubicin—testicular cancer	0.000203	0.000458	CcSEcCtD
Oxcarbazepine—Skin disorder—Methotrexate—testicular cancer	0.000202	0.000458	CcSEcCtD
Oxcarbazepine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—testicular cancer	0.000202	0.000457	CcSEcCtD
Oxcarbazepine—Hyperhidrosis—Methotrexate—testicular cancer	0.000201	0.000455	CcSEcCtD
Oxcarbazepine—Discomfort—Epirubicin—testicular cancer	0.000201	0.000454	CcSEcCtD
Oxcarbazepine—Malaise—Doxorubicin—testicular cancer	0.000199	0.000451	CcSEcCtD
Oxcarbazepine—Dry mouth—Epirubicin—testicular cancer	0.000199	0.00045	CcSEcCtD
Oxcarbazepine—Vertigo—Doxorubicin—testicular cancer	0.000198	0.000449	CcSEcCtD
Oxcarbazepine—Anorexia—Methotrexate—testicular cancer	0.000198	0.000449	CcSEcCtD
Oxcarbazepine—Syncope—Doxorubicin—testicular cancer	0.000198	0.000448	CcSEcCtD
Oxcarbazepine—Leukopenia—Doxorubicin—testicular cancer	0.000198	0.000447	CcSEcCtD
Oxcarbazepine—Confusional state—Epirubicin—testicular cancer	0.000196	0.000445	CcSEcCtD
Oxcarbazepine—Palpitations—Doxorubicin—testicular cancer	0.000195	0.000442	CcSEcCtD
Oxcarbazepine—Anaphylactic shock—Epirubicin—testicular cancer	0.000195	0.000441	CcSEcCtD
Oxcarbazepine—Hypotension—Methotrexate—testicular cancer	0.000195	0.00044	CcSEcCtD
Oxcarbazepine—Loss of consciousness—Doxorubicin—testicular cancer	0.000194	0.000439	CcSEcCtD
Oxcarbazepine—Infection—Epirubicin—testicular cancer	0.000194	0.000438	CcSEcCtD
Oxcarbazepine—Cough—Doxorubicin—testicular cancer	0.000193	0.000436	CcSEcCtD
Oxcarbazepine—Shock—Epirubicin—testicular cancer	0.000192	0.000434	CcSEcCtD
Oxcarbazepine—Convulsion—Doxorubicin—testicular cancer	0.000191	0.000433	CcSEcCtD
Oxcarbazepine—Nervous system disorder—Epirubicin—testicular cancer	0.000191	0.000432	CcSEcCtD
Oxcarbazepine—Thrombocytopenia—Epirubicin—testicular cancer	0.000191	0.000432	CcSEcCtD
Oxcarbazepine—Hypertension—Doxorubicin—testicular cancer	0.000191	0.000432	CcSEcCtD
Oxcarbazepine—Tachycardia—Epirubicin—testicular cancer	0.00019	0.00043	CcSEcCtD
Oxcarbazepine—Musculoskeletal discomfort—Methotrexate—testicular cancer	0.00019	0.000429	CcSEcCtD
Oxcarbazepine—Skin disorder—Epirubicin—testicular cancer	0.000189	0.000428	CcSEcCtD
Oxcarbazepine—Hyperhidrosis—Epirubicin—testicular cancer	0.000188	0.000426	CcSEcCtD
Oxcarbazepine—Insomnia—Methotrexate—testicular cancer	0.000188	0.000426	CcSEcCtD
Oxcarbazepine—Chest pain—Doxorubicin—testicular cancer	0.000188	0.000426	CcSEcCtD
Oxcarbazepine—Arthralgia—Doxorubicin—testicular cancer	0.000188	0.000426	CcSEcCtD
Oxcarbazepine—Myalgia—Doxorubicin—testicular cancer	0.000188	0.000426	CcSEcCtD
Oxcarbazepine—Anxiety—Doxorubicin—testicular cancer	0.000187	0.000424	CcSEcCtD
Oxcarbazepine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—testicular cancer	0.000187	0.000423	CcSEcCtD
Oxcarbazepine—Discomfort—Doxorubicin—testicular cancer	0.000186	0.00042	CcSEcCtD
Oxcarbazepine—Anorexia—Epirubicin—testicular cancer	0.000186	0.00042	CcSEcCtD
Oxcarbazepine—Dyspnoea—Methotrexate—testicular cancer	0.000186	0.00042	CcSEcCtD
Oxcarbazepine—Somnolence—Methotrexate—testicular cancer	0.000185	0.000419	CcSEcCtD
Oxcarbazepine—Dry mouth—Doxorubicin—testicular cancer	0.000184	0.000416	CcSEcCtD
Oxcarbazepine—Dyspepsia—Methotrexate—testicular cancer	0.000183	0.000415	CcSEcCtD
Oxcarbazepine—Hypotension—Epirubicin—testicular cancer	0.000182	0.000412	CcSEcCtD
Oxcarbazepine—Confusional state—Doxorubicin—testicular cancer	0.000182	0.000411	CcSEcCtD
Oxcarbazepine—Decreased appetite—Methotrexate—testicular cancer	0.000181	0.00041	CcSEcCtD
Oxcarbazepine—Anaphylactic shock—Doxorubicin—testicular cancer	0.00018	0.000408	CcSEcCtD
Oxcarbazepine—Gastrointestinal disorder—Methotrexate—testicular cancer	0.00018	0.000407	CcSEcCtD
Oxcarbazepine—Fatigue—Methotrexate—testicular cancer	0.00018	0.000406	CcSEcCtD
Oxcarbazepine—Infection—Doxorubicin—testicular cancer	0.000179	0.000405	CcSEcCtD
Oxcarbazepine—Pain—Methotrexate—testicular cancer	0.000178	0.000403	CcSEcCtD
Oxcarbazepine—Musculoskeletal discomfort—Epirubicin—testicular cancer	0.000178	0.000402	CcSEcCtD
Oxcarbazepine—Shock—Doxorubicin—testicular cancer	0.000177	0.000401	CcSEcCtD
Oxcarbazepine—Nervous system disorder—Doxorubicin—testicular cancer	0.000177	0.0004	CcSEcCtD
Oxcarbazepine—Thrombocytopenia—Doxorubicin—testicular cancer	0.000177	0.000399	CcSEcCtD
Oxcarbazepine—Insomnia—Epirubicin—testicular cancer	0.000176	0.000399	CcSEcCtD
Oxcarbazepine—Tachycardia—Doxorubicin—testicular cancer	0.000176	0.000398	CcSEcCtD
Oxcarbazepine—Skin disorder—Doxorubicin—testicular cancer	0.000175	0.000396	CcSEcCtD
Oxcarbazepine—Hyperhidrosis—Doxorubicin—testicular cancer	0.000174	0.000394	CcSEcCtD
Oxcarbazepine—Dyspnoea—Epirubicin—testicular cancer	0.000174	0.000393	CcSEcCtD
Oxcarbazepine—Somnolence—Epirubicin—testicular cancer	0.000173	0.000392	CcSEcCtD
Oxcarbazepine—Anorexia—Doxorubicin—testicular cancer	0.000172	0.000389	CcSEcCtD
Oxcarbazepine—Feeling abnormal—Methotrexate—testicular cancer	0.000172	0.000388	CcSEcCtD
Oxcarbazepine—Dyspepsia—Epirubicin—testicular cancer	0.000172	0.000388	CcSEcCtD
Oxcarbazepine—Gastrointestinal pain—Methotrexate—testicular cancer	0.00017	0.000385	CcSEcCtD
Oxcarbazepine—Decreased appetite—Epirubicin—testicular cancer	0.000169	0.000383	CcSEcCtD
Oxcarbazepine—Hypotension—Doxorubicin—testicular cancer	0.000168	0.000381	CcSEcCtD
Oxcarbazepine—Gastrointestinal disorder—Epirubicin—testicular cancer	0.000168	0.000381	CcSEcCtD
Oxcarbazepine—Fatigue—Epirubicin—testicular cancer	0.000168	0.00038	CcSEcCtD
Oxcarbazepine—Pain—Epirubicin—testicular cancer	0.000167	0.000377	CcSEcCtD
Oxcarbazepine—Constipation—Epirubicin—testicular cancer	0.000167	0.000377	CcSEcCtD
Oxcarbazepine—Urticaria—Methotrexate—testicular cancer	0.000165	0.000374	CcSEcCtD
Oxcarbazepine—Abdominal pain—Methotrexate—testicular cancer	0.000165	0.000372	CcSEcCtD
Oxcarbazepine—Body temperature increased—Methotrexate—testicular cancer	0.000165	0.000372	CcSEcCtD
Oxcarbazepine—Musculoskeletal discomfort—Doxorubicin—testicular cancer	0.000164	0.000372	CcSEcCtD
Oxcarbazepine—Insomnia—Doxorubicin—testicular cancer	0.000163	0.000369	CcSEcCtD
Oxcarbazepine—Dyspnoea—Doxorubicin—testicular cancer	0.000161	0.000364	CcSEcCtD
Oxcarbazepine—Feeling abnormal—Epirubicin—testicular cancer	0.000161	0.000363	CcSEcCtD
Oxcarbazepine—Somnolence—Doxorubicin—testicular cancer	0.00016	0.000363	CcSEcCtD
Oxcarbazepine—Gastrointestinal pain—Epirubicin—testicular cancer	0.000159	0.000361	CcSEcCtD
Oxcarbazepine—Dyspepsia—Doxorubicin—testicular cancer	0.000159	0.000359	CcSEcCtD
Oxcarbazepine—Decreased appetite—Doxorubicin—testicular cancer	0.000157	0.000355	CcSEcCtD
Oxcarbazepine—Gastrointestinal disorder—Doxorubicin—testicular cancer	0.000156	0.000352	CcSEcCtD
Oxcarbazepine—Fatigue—Doxorubicin—testicular cancer	0.000155	0.000352	CcSEcCtD
Oxcarbazepine—Urticaria—Epirubicin—testicular cancer	0.000155	0.00035	CcSEcCtD
Oxcarbazepine—Constipation—Doxorubicin—testicular cancer	0.000154	0.000349	CcSEcCtD
Oxcarbazepine—Pain—Doxorubicin—testicular cancer	0.000154	0.000349	CcSEcCtD
Oxcarbazepine—Abdominal pain—Epirubicin—testicular cancer	0.000154	0.000349	CcSEcCtD
Oxcarbazepine—Body temperature increased—Epirubicin—testicular cancer	0.000154	0.000349	CcSEcCtD
Oxcarbazepine—Hypersensitivity—Methotrexate—testicular cancer	0.000153	0.000347	CcSEcCtD
Oxcarbazepine—Asthenia—Methotrexate—testicular cancer	0.000149	0.000338	CcSEcCtD
Oxcarbazepine—Feeling abnormal—Doxorubicin—testicular cancer	0.000149	0.000336	CcSEcCtD
Oxcarbazepine—Gastrointestinal pain—Doxorubicin—testicular cancer	0.000147	0.000334	CcSEcCtD
Oxcarbazepine—Pruritus—Methotrexate—testicular cancer	0.000147	0.000333	CcSEcCtD
Oxcarbazepine—Hypersensitivity—Epirubicin—testicular cancer	0.000144	0.000325	CcSEcCtD
Oxcarbazepine—Urticaria—Doxorubicin—testicular cancer	0.000143	0.000324	CcSEcCtD
Oxcarbazepine—Abdominal pain—Doxorubicin—testicular cancer	0.000143	0.000323	CcSEcCtD
Oxcarbazepine—Body temperature increased—Doxorubicin—testicular cancer	0.000143	0.000323	CcSEcCtD
Oxcarbazepine—Diarrhoea—Methotrexate—testicular cancer	0.000142	0.000322	CcSEcCtD
Oxcarbazepine—Asthenia—Epirubicin—testicular cancer	0.00014	0.000316	CcSEcCtD
Oxcarbazepine—Pruritus—Epirubicin—testicular cancer	0.000138	0.000312	CcSEcCtD
Oxcarbazepine—Dizziness—Methotrexate—testicular cancer	0.000138	0.000312	CcSEcCtD
Oxcarbazepine—Diarrhoea—Epirubicin—testicular cancer	0.000133	0.000302	CcSEcCtD
Oxcarbazepine—Hypersensitivity—Doxorubicin—testicular cancer	0.000133	0.000301	CcSEcCtD
Oxcarbazepine—Vomiting—Methotrexate—testicular cancer	0.000132	0.0003	CcSEcCtD
Oxcarbazepine—Rash—Methotrexate—testicular cancer	0.000131	0.000297	CcSEcCtD
Oxcarbazepine—Dermatitis—Methotrexate—testicular cancer	0.000131	0.000297	CcSEcCtD
Oxcarbazepine—Headache—Methotrexate—testicular cancer	0.00013	0.000295	CcSEcCtD
Oxcarbazepine—Asthenia—Doxorubicin—testicular cancer	0.000129	0.000293	CcSEcCtD
Oxcarbazepine—Dizziness—Epirubicin—testicular cancer	0.000129	0.000292	CcSEcCtD
Oxcarbazepine—Pruritus—Doxorubicin—testicular cancer	0.000128	0.000289	CcSEcCtD
Oxcarbazepine—Vomiting—Epirubicin—testicular cancer	0.000124	0.00028	CcSEcCtD
Oxcarbazepine—Nausea—Methotrexate—testicular cancer	0.000124	0.00028	CcSEcCtD
Oxcarbazepine—Diarrhoea—Doxorubicin—testicular cancer	0.000123	0.000279	CcSEcCtD
Oxcarbazepine—Rash—Epirubicin—testicular cancer	0.000123	0.000278	CcSEcCtD
Oxcarbazepine—Dermatitis—Epirubicin—testicular cancer	0.000123	0.000278	CcSEcCtD
Oxcarbazepine—Headache—Epirubicin—testicular cancer	0.000122	0.000276	CcSEcCtD
Oxcarbazepine—Dizziness—Doxorubicin—testicular cancer	0.000119	0.00027	CcSEcCtD
Oxcarbazepine—Nausea—Epirubicin—testicular cancer	0.000116	0.000262	CcSEcCtD
Oxcarbazepine—Vomiting—Doxorubicin—testicular cancer	0.000115	0.000259	CcSEcCtD
Oxcarbazepine—Rash—Doxorubicin—testicular cancer	0.000114	0.000257	CcSEcCtD
Oxcarbazepine—Dermatitis—Doxorubicin—testicular cancer	0.000114	0.000257	CcSEcCtD
Oxcarbazepine—Headache—Doxorubicin—testicular cancer	0.000113	0.000256	CcSEcCtD
Oxcarbazepine—Nausea—Doxorubicin—testicular cancer	0.000107	0.000242	CcSEcCtD
